Table 1.
Clinical details of the patients.
ID | Age (y) | Sex | Histo | Location of the lesion | LVol (cm3) | Neurol. deficits |
ShDi (mm) | Impaired NVC | funct. task | r thresh. | |
---|---|---|---|---|---|---|---|---|---|---|---|
preop | postop | ||||||||||
1 | 55 | m | Men | l temporal | 48.9 | no | no | 0 | no | lang | 0.3 |
2 | 76 | m | GB | r frontal | 77.9 | no | no | 2 | yes | sm | 0.13 |
3 | 67 | m | AOG | l frontal | 102 | no | no | 22 | yes | lang | 0.12 |
4 | 54 | m | GB | r trigonal | 58.1 | yes | no | 9 | yes | sm | 0.21 |
5 | 41 | m | AA | l parietal | 71.7 | no | no | 4 | no | sm | 0.3 |
6 | 59 | m | GB | r temporal | 232 | yes | no | 13 | yes | sm | 0.17 |
7 | 71 | m | GB | l temporal | 24.6 | no | no | 8 | no | lang | 0.3 |
8 | 43 | m | AOG | r central | 40.2 | yes | no | 0 | no | sm | 0.3 |
9 | 31 | m | LGA | l frontal | 29.9 | no | no | 4 | no | lang | 0.3 |
10 | 36 | f | AVM | r temporal | 0.3 | no | no | 2 | no | sm | 0.3 |
11 | 73 | m | Cav | l temporal | 5.9 | no | no | 0 | yes | lang | 0.16 |
12 | 44 | m | AVM | l postcentral | 7.9 | no | yes | 0 | no | sm | 0.3 |
13 | 41 | f | AOG | l frontal | 67.0 | yes | yes | 5 | no | sm | 0.3 |
14 | 51 | f | GB | r frontal | 15.7 | yes | no | 2 | yes | sm | 0.18 |
15 | 27 | m | AA | l fronto-insular | 35.8 | no | no | 0 | no | lang | 0.3 |
16 | 58 | f | GB | l temporal | 36.7 | no | yes* | 9 | no | lang | 0.3 |
17 | 45 | m | AA | l fronto-temp. | 58.6 | no | no | 8 | yes | lang | 0.26 |
18 | 27 | f | LGA | l frontal | 3.0 | no | yes* | 0 | no | lang | 0.3 |
19 | 24 | f | GG | l temporal | 2.7 | no | yes* | 5 | no | lang | 0.3 |
20 | 68 | f | GB | l frontal | 53.2 | yes | yes | 0 | no | lang | 0.3 |
Histo: histology of the lesion; LVol: lesion volume; Neurol. deficits preop/postop: preoperative/postoperative neurologic deficits; ShDi: shortest distance between cortical area with important brain function and lesion border; NVC: neurovascular coupling; funct. task: functional task; lang: language task; sm: sensorimotor task; r thresh.: correlation threshold used for BOLD fMRI data evaluation. Note: numbers lesser than 0.3 are the reduced threshold values at that an fMRI activity was visible. Men: meningioma; GB: glioblastoma WHO grade IV; AOG: anaplastic oligodendroglioma WHO grade III; AA: anaplastic astrocytoma WHO grade III; GG: ganglioglioma WHO grade I; LGA: low-grade astrocytoma WHO grade II; AVM: arteriovenous malformation; Cav: cavernoma.